Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,731 | 2,786 | 2,553 | 1,712 | 1,330 |
| Operating Income | -2,731 | -2,786 | -2,553 | -1,712 | -1,330 |
| Interest Expense | 0 | 0 | 0 | 1 | 2 |
| Pre-tax Income | -2,731 | -2,786 | -2,553 | -1,713 | -1,332 |
| Net Income Continuous | -2,731 | -2,786 | -2,553 | -1,713 | -1,332 |
| Net Income | $-2,731 | $-2,786 | $-2,553 | $-1,713 | $-1,332 |
| EPS Basic Total Ops | -584.71 | -802.10 | 815.59 | -2,062.97 | -1,679.16 |
| EPS Basic Continuous Ops | -585.10 | -802.46 | 983.66 | -825.09 | -1,671.74 |
| EPS Diluted Total Ops | -584.71 | -802.10 | 815.59 | -2,062.97 | -1,679.16 |
| EPS Diluted Continuous Ops | -585.10 | -802.46 | 983.66 | -825.09 | -1,671.74 |
| EBITDA(a) | $-2,731 | $-2,786 | $-2,553 | $-1,712 | $-1,330 |